Abiopharma

🔍 Sanghi Steve (Director)

Company: MICROCHIP TECHNOLOGY INC (MCHP)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Acquired 28,853 shares of Common Stock at $80.26 per share (Direct)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,446,988.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 11,931 shares of Common Stock at $80.26 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 9,435,057.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Sold 28,853 shares of Restricted Stock Units at $80.26 per share (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 57,708.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: Of the 9,446,988 shares held, 3,541,116 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.
• F2: Of the 9,435,057 shares held, 3,529,185 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.
• F3: The restricted stock units will vest in two equal quarterly installments of 28,853 shares on May 15, 2026 and August 15, 2025, and two equal quarterly installments of 28,854 shares on November 15, 2026 and February 15, 2027, as long as the individual remains a service provider through the vesting date(s). Vested shares were delivered to the Reporting Person upon vest.